Cytotoxic chemotherapy combination

0 marketed 2 in Phase 3

This page covers all Cytotoxic chemotherapy combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Ribonucleotide reductase, DNA polymerase, thymidylate synthase.

Targets

Ribonucleotide reductase, DNA polymerase, thymidylate synthase

Phase 3 pipeline (2)

Gemcitabine + S-1 · AstraZeneca · Oncology
Gemcitabine and S-1 are cytotoxic chemotherapy agents that work synergistically to inhibit DNA synthesis and cell division in cancer cells.
Intensified chemotherapy · Italian Sarcoma Group · Oncology
Intensified chemotherapy uses higher doses or more aggressive combinations of cytotoxic agents to maximize tumor cell kill in sarcoma patients.